CS
PRNB

Credit Suisse’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Credit Suisse’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,969
Closed -$3.23M – 4209
2020
Q2 		$3.23M Buy
53,969
+28,016
+108% +$1.73M ﹤0.01% 2019
2020
Q1 		$1.54M Sell
25,953
-8,003
-24% -$467K ﹤0.01% 2307
2019
Q4 		$1.86M Buy
33,956
+25,170
+286% +$940K ﹤0.01% 2651
2019
Q3 		$247K Buy
8,786
+241
+3% +$8.84K ﹤0.01% 3785
2019
Q2 		$283K Buy
+8,545
New +$267K ﹤0.01% 3709

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Credit Suisse's PRNB Position: Q3 2020 in Review

Credit Suisse sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 53,969 shares — an estimated $3.23M sold.

Credit Suisse first reported a position in PRNB in Q2 2019 and held it in 5 quarters. The position peaked at $3.23M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Credit Suisse reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Credit Suisse sold 53,969 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $3.23M.
  • Credit Suisse first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 5 quarters.
  • Credit Suisse's Principia Biopharma Inc. Common Stock position peaked at $3.23M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Credit Suisse's 13F filing for Q3 2020, filed 13 Nov 2020.